These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32013913)

  • 1. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
    Jiang T; Gu J; Zhang P; Chen W; Chang Q
    BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
    Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
    Ahn J; Woo SJ; Chung H; Park KH
    Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
    Abd Elhamid AH; Mohamed AAEA; Khattab AM
    BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.
    Göncü T; Özdek S; Ünlü M
    Eur J Ophthalmol; 2014; 24(1):88-93. PubMed ID: 23787453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
    Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
    Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
    Park DH; Shin JP; Kim SY
    Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy.
    Takamura Y; Shimura M; Katome T; Someya H; Sugimoto M; Hirano T; Sakamoto T; Gozawa M; Matsumura T; Inatani M;
    Br J Ophthalmol; 2018 Oct; 102(10):1351-1357. PubMed ID: 29343528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
    Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
    Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
    Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
    BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
    Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
    Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
    Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
    Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
    Chen GH; Tzekov R; Mao SH; Tong YH; Jiang FZ; Li WS
    Eye (Lond); 2022 Mar; 36(3):619-626. PubMed ID: 33824510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of intravitreal conbercept injection after vitrectomy for the treatment of proliferative diabetic retinopathy.
    Ren X; Bu S; Zhang X; Jiang Y; Tan L; Zhang H; Li X
    Eye (Lond); 2019 Jul; 33(7):1177-1183. PubMed ID: 30872770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy.
    Lu Q; Lu L; Chen B; Chen W; Lu P
    Can J Ophthalmol; 2019 Jun; 54(3):291-296. PubMed ID: 31109466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Antoszyk AN; Glassman AR; Beaulieu WT; Jampol LM; Jhaveri CD; Punjabi OS; Salehi-Had H; Wells JA; Maguire MG; Stockdale CR; Martin DF; Sun JK;
    JAMA; 2020 Dec; 324(23):2383-2395. PubMed ID: 33320223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
    Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
    Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.